Economy · India
Analysts flag growth upside for select Indian pharma stocks
Jefferies, a global investment bank, identified Gland Pharma and Fortis Health as small- and mid-cap healthcare stocks with an estimated upside of up to 26 percent. The recommendation was part of Jefferies’ list of small- and mid-cap picks in the Indian healthcare sector. Business Today reported that Gland Pharma, Caplin Point and Nephrocare are three pharma companies that analysts expect to deliver strong growth. Both outlets presented the information as investment opportunities rather than reporting any corporate actions or regulatory changes. No other outlets provided conflicting views, and the coverage did not mention any immediate market moves or price changes.
How outlets across the spectrum covered it
L 0 C 2 R 0
- Centre (2): Business Today, The Financial Express